Share
    NEW SEARCH RETURN TO SEARCH RESULTS
Number: 201310160 Principal Investigator: Wang-Gillam, Andrea
Title: An Open-Label, Phase I Dose Escalation Trial of TH-302 in Combination with Gemcitabine and Nab-Paclitaxel in Previously Untreated Subjects with Metastatic or Locally Advanced Unresectable Pancreatic Adenocarcinoma
Phase: I Disease Site: Pancreas
Participating Site(s):
 
 
Contact: 800-600-3606 or info@ccadmin.wustl.edu

Description:
The purpose of this research study is to investigate the safety of the study drug TH-302 in combination with two other chemotherapy drugs in patients with advanced pancreatic cancer who have not been treated before, and to find out the best dose to further test the study drug.
 
More Information:
ClinicalTrials.Gov Link
Internal Protocol Documents (requires Siteman administrative database password)